Fig. 5From: Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibodyExample of tumour uptake of 89Zr-RG7356 at 96 h p.i.. Tumour lesion mediastinal/in the aorta–pulmonary window (patient 8, 450 mg cohort). a Low dose CT. b Attenuation-corrected PET. c Fused imageBack to article page